BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion BPC 157: Miracle Healing Peptide or Hidden Danger? Is BPC 157 Legal? Understanding Its Status and Implications